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In industrialized countries, gastroenteritis
incidence remains high, although improved
hygiene and treatment have decreased deaths
substantially (1,2). Up-to-date estimates of the
incidence, disease burden (absence from work or
school, bed rest, and use of medication),
microbiologic causes, transmission routes, and
pathogen sources are necessary to control
gastroenteritis effectively and evaluate preven-
tive measures. While numerous studies have
addressed the incidence of specific pathogens in
selected populations, little is known about the
overall incidence and relative contribution of the
broad range of pathogens that cause gastroen-
teritis. In the Netherlands, data on the incidence
of gastroenteritis are available from studies in
the early 1990s in the general population and in
general practices and from continuous labora-
tory-based surveillance (3,4). The incidence in
the general population was estimated to be 450
per 1,000 person years in 1991 (5,6). Patients
were tested for Salmonella and Campylobacter
spp., which were detected in 1.5% and 4.6%,
respectively. Of these patients, 10% reported
visiting their general practitioner (GP), and an
additional 10% reported phoning their GP. The
incidence of gastroenteritis for which a GP was
consulted was estimated to be 15 per 1,000
person years in two regions from 1987 to 1991 (7)
and 9 per 1,000 person years in 1992-1993 (8). In
these two studies, stool samples were tested for
bacterial pathogens; a small subset of these were
tested for rotavirus and adenovirus. In most
patients (67% in 1987 to 1991, 80% in 1992 to
1993), no pathogen could be detected.
In the years following these studies, new
pathogens have been identified, such as
Cyclospora, and diagnostic methods have been
designed for others (Norwalk-like viruses,
astrovirus). In addition, to meet the European
regulations on protection against zoonotic
agents, preventive measures in the veterinary
sector have been implemented to decrease
Salmonella infections in poultry (9-11). There-
fore, in 1996, a new study was started among
patients consulting a GP. The aims were to
estimate the current incidence, study the role of
several pathogens, and identify risk factors for
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microorganism-specific gastroenteritis. Unique
to this study, controls were included and stool
samples were tested for a broad panel of pathogens.
The same network of GPs was used as in the 1992-
1993 study, allowing a comparative analysis.
Materials and Methods
The study was performed in cooperation with
the network of GPs from the Continuous
Morbidity Registration of the Netherlands
Institute of Primary Health Care. The network
consists of approximately 44 practices that cover
1% of the Dutch population and are representa-
tive of it regarding age, gender, regional
distribution, and degree of urbanization. All
practices reported the number of consultations
for gastroenteritis by age group, gender, practice,
and week of consultation (reporting study).
Approximately 34 of the practices (33 in 1996;
35 in 1997; 36 in 1998; and 34 in 1999)
participated in the case-control study. Patients
who consulted a participating GP were asked to
complete a questionnaire and submit a stool
sample. For each case, a control was recruited on
the same day from patients who consulted their
GP for nongastrointestinal complaints. Controls
were matched by age group (<11 years, 12 years
and older). Thirty-one GPs registered the
number of the study package (containing a
questionnaire and a stool kit), which was handed
out to a participant, on a registration form with
age and gender. Participants collected the stool
samples and completed the questionnaire at
home, and then sent the samples and question-
naires directly to the National Institute of Public
Health and the Environment. The questionnaire
addressed health status, demographic character-
istics, disease burden, clinical manifestations,
and risk factors. Stool samples were tested for
Salmonella, Campylobacter, Shigella, and
Yersinia  by routine culture; for verocytotoxin-
producing Escherichia coli by polymerase chain
reaction for genes for verocytotoxin 1 and
verocytotoxin 2 and eae gene; E. coli O157 by
culture on Sorbitol McConkey Agar (12,13);
rotavirus and adenovirus by enzyme-linked
immunoassay (ELISA) (Rotaclone and Adenoclone
from Meridian Diagnostics, Cincinnati, OH);
astrovirus by ELISA (IDEIA from DAKO
Diagnostics, Cambridgeshire, UK); Norwalk-like
viruses by reverse transcriptase-polymerase
chain reaction [14]; intestinal parasites by
microscopy after fixation in sodium acetate,
acetic acid, and formalin; helminthic ova, cysts,
and trophozoites by wet film (iodine stained or
unstained); for cysts by Ridley concentration
(iodine stained); for cysts of Cryptosporidium,
Cyclospora, and Isospora belli, by Ridley
concentration (Ziehl-Nielsen staining); for tro-
phozoites of protozoa and, to a lesser extent, for
cysts, by permanent stained smear (Haemaluin
staining) (15-20). Samples from May 1998 until
April 1999 were also tested retrospectively for
Sapporo-like viruses (21). All stool samples were
stored for future investigations. Standardized
protocols were used.
The case definition of gastroenteritis used in
this study was three or more loose stools in 24
hours; or diarrhea with two additional gas-
trointestinal symptoms (vomiting, nausea, fever,
abdominal cramps, abdominal pain, blood in
stool, mucus in stool); or vomiting with two
additional gastrointestinal symptoms (diarrhea,
nausea, fever, abdominal cramps, abdominal
pain, blood in stool, mucus in stool) preceded by a
symptom-free period of 2 weeks.
Statistical Analyses
Crude incidence was calculated from the
reporting study, corrected for incomplete years.
Corrections for incompleteness of participation of
GPs and cases and for list inflation (persons no
longer belonging to the practice population) were
used to calculate an adjusted incidence. List
inflation was calculated on the basis of findings in
an ongoing, population-based study, performed
in the same general practices (22).
The response rate in cases and controls was
estimated by using the registration forms.
Reported cases and cases in the case-control
study were compared by week, practice, age
group, and gender to estimate the number of
cases in both and each study part. The total cases
reported, recruited for the case-control study, or
both were used to estimate an incidence corrected
for nonresponse. A logistic regression model was
used to identify factors independently associated
with total response. A variable was excluded if
exclusion did not significantly decrease the log
likelihood of the model. Because information on
the response of recruited cases was too limited to
study effects of patients and practice characteris-
tics, only the total of known cases to participating
cases was studied in this model.
The effects on incidence of age and gender of
the patient, year of study, degree of urbanization,84 Emerging Infectious Diseases Vol. 7, No. 1, January–February 2001
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region of the Netherlands, and participation of
the sentinel practice in the case-control study
were estimated univariately; independent effects
were estimated by using Poisson regression. A
variable was excluded from the model if exclusion
did not increase the deviance significantly. Cases
that did not meet the case definition and controls
that did, according to self-reported symptoms in
the questionnaire, were excluded from analyses.
Results
The overall incidence of gastroenteritis from
May 1996 to April 1999 was 58.0 per 10,000
person years (2,264 cases/390,417 person years)
based on the unadjusted number of reported
patients of all sentinel practices. A high seasonal
peak was observed in the winter of 1996
(maximum in week 9), and lower peaks in 1998
and 1999 (Figure). Summer peaks occurred in all
years of the study but varied in period and size.
The univariate and multivariate analyses of
incidence yielded similar results (Table 1). In the
first year of the study (May 1996-April 1997),
incidence was lower than in the second (May
1997-April 1998) and third years (May 1998-April
1999). A higher incidence was observed in
practices that participated in the case-control
study, practices in rural and urban areas
(compared to those with intermediate degree of
urbanization), and practices in the East, West,
and South. The incidence was slightly higher for
women than for men and decreased from the
youngest age group to the 15- to 24-year age
group. The 40- to 64-year-old patients had the
lowest incidence. The rate ratios for the different
age groups were similar for men and women.
The response of patients was 78% (695
questionnaires completed out of 888 cases
registered on registration forms). A total of 2,553
cases were reported, recruited for the case-
control study, or both. Of these, 1,138 (45%)
patients were recruited, 888 (35%) participated
in the case-control study, and 2,165 (85%) were
reported. The incidence corrected for incomplete
participation of patients and GPs was 77.7 per
10,000 person years (2,553 cases/328,438 person
years), according to data from GPs participating
in the case-control study. The estimated list
inflation was 2.5%. Adjusting the denominator
for list inflation yielded a final incidence of 79.7
per 10,000 person years (2,553 cases/320,227
person years).
The percentage of patients recruited by GPs
decreased during the study and was higher in the
North and South (Table 2). The highest
participation rate was for patients 25-64 years of
age, mainly because a higher proportion were
recruited. Participation was relatively low for 15-
to 24-year-old patients.
The response of controls who were recruited
was 73% (554 questionnaires completed out of
765 study packages registered). The lowest
response rates for controls (42%) were found in
the 10- to 19-year-old age group. The response for
female controls was slightly higher than for male
controls (78% versus 68%). Participation was
highest for controls recruited in 1996 (82%) and
lowest in 1999 (63%).
Case-Control Study
Population of Participating Practices
The distribution of age, gender, and degree of
urbanization in the study population was similar
to that of the Dutch population.  The North was
overrepresented (20% in participating practices,
10% in Dutch population); the West was
underrepresented (32% in practices vs. 44% in
the population).
Cases and Controls
From May 1996 until April 1999, 985 cases
and 717 controls returned a questionnaire to the
National Institute of Public Health and the
Environment. Of these, 878 cases and 581
controls  could be included in the analyses. Stool
samples were examined from 857 (98%) patients
and 574 (99%) controls. The median age of
patients (29 years) was significantly lower than
Figure. Incidence of gastroenteritis per 10,000 person
years, from reporting of all sentinel practices, the
Netherlands, January 1996 to April 1999.85 Vol. 7, No. 1, January–February 2001 Emerging Infectious Diseases
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that of controls (37 years). Gastrointestinal
complaints of longer than 1 month were more
frequent in patients (31.5%) than in controls
(7.3%). The percentage of patients (18%) under
treatment of a specialist was similar to that of
controls, as was the number of GP consultations
in the last 3 months (1 consultation). Patients
were slightly more often born outside the
Netherlands than controls, and the educational
level of patients was higher than that of controls
(both not statistically significantly).
Clinical Symptoms of Patients
Almost all patients reported loose stools
(Table 3). Other commonly reported symptoms
were frequent stools, abdominal pain, abdominal
cramps, and nausea. Only 12 (1.4%) patients
reported vomiting and no diarrhea. In cases with
a higher frequency of stools than normal, the
median of the maximum frequency was 6 times in
24 hours (first quartile-third quartile: 4-8 times
in 24 hours). The median duration of symptoms
before a GP was consulted was 6 days (first
quartile to third quartile: 3-20 days); 20% of
patients had been symptomatic for more than 4
weeks before consulting a GP.
Bed rest was required for 47% of patients for
a median of 2 days (mean 3.1 days); 41% of the
children who regularly visited a day-care center
had to stay home for a median of 3 days (mean 3.2
days), 58% of schoolchildren were absent from
school for a median duration of 3 days (mean 3.8
days), and 60% of working patients were absent
from work for a median duration of 2 days (mean
3.1 days). In 8% of cases, someone had to miss
school or work for a median of 1.5 days (average
2.0 days) to care for the patient; 56% of patients
used medication for gastroenteritis: 4% used
antibiotics, 18% analgesics, 27% antidiarrheic
medication, 10% oral rehydration solution, and
21% additional medications.
Symptoms and Diagnoses of Controls
A small proportion of controls (6.7%) reported
consulting a GP for gastrointestinal symptoms
when they were recruited for the study but did
Table 1. Univariate and multivariate Poisson regression analyses of the incidence per 10,000 person years
Incidence per 10,000         Crude Univariate Poisson regression Multivariate Poisson regression
person years incidence RRa 95% CIa RR 95% CI
Study year
  May 96-Apr 97   52.4 1.00        - 1.00        -
  May 97-Apr 98   62.4 1.19 1.08-1.32 1.19 1.08-1.32
  May 98-Apr 99   65.6 1.25 1.13-1.38 1.23 1.11-1.36
Participation in  case-
      control study
  Yes   65.8 2.51 2.13-2.97 2.71 2.28-3.22
  No   26.2 1.00        - 1.00        -
Urbanization
  Low   57.0 1.04 0.92-1.17 1.18 1.04-1.34
  Intermediate   55.5 1.00        - 1.00        -
  High   88.9 1.62 1.47-1.79 1.25 1.11-1.41
Region
  North   28.7 0.39 0.34-0.45 0.35 0.29-0.40
  East   71.3 0.97 0.88-1.07 0.93 0.83-1.05
  West   76.0 1.00        - 1.00        -
  South   55.5 0.75 0.68-0.84 0.78 0.69-0.88
Gender
  Male   56.8 1.00        - 1.00        -
  Female   63.4 1.12 1.03-1.21 1.12 1.04-1.22
Age (in years)
  <1 360.4 5.53 4.49-6.82 5.54 4.50-6.83
  1-4 221.5 3.40 2.94-3.94 3.36 2.90-3.89
  5-14   65.1 1.00        - 1.00        -
  15-24   51.7 0.79 0.67-0.94 0.79 0.67-0.93
  25-39   55.9 0.86 0.75-0.98 0.84 0.73-0.97
  40-64   36.5 0.56 0.48-0.65 0.56 0.48-0.65
  >65   47.7 0.73 0.62-0.87 0.72 0.61-0.85
aRR = relative risk; CI = confidence interval.86 Emerging Infectious Diseases Vol. 7, No. 1, January–February 2001
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Pathogens
The most frequently detected pathogens in
cases were Campylobacter,  Giardia lamblia,
rotavirus, Norwalk-like viruses, and Salmonella
(Table 4). Bacterial pathogens were found almost
solely in cases, except for Yersinia  and
verocytotoxin-producing  E. coli. All isolated
Yersinia spp. were nonpathogenic serotypes. The
verocytotoxin-producing E. coli serotypes found
in controls were different from those found in
patients but included pathogenic types, such as
O26. E. coli O157 K-H- was isolated from one
case. The percentages of Campylobacter, Salmo-
nella, and Salmonella Enteritidis did not differ
significantly over the study years. Viral
pathogens were found in 1% to 5% of patients and
in a small percentage of controls. The possibly
nonpathogenic parasite Dientamoeba fragilis
and the nonpathogenic parasite Blastocystis
hominis  were common and were found more
frequently in controls than in patients.
Table 2. Multivariate logistic regression analyses of the selection of participating cases from all cases that were
reported or participated in the case-control study, the Netherlands
Recruited or % Recruited % Part. % Total  ORc for
   reported      by GPa  casesb response response  95% CId
Gender   nie
  Male 1,178 45 79 35
  Female 1,370 44 78 35
Age (yrs)
  0    123 34 76 26 0.84 0.51-1.37
  1-4    452 40 76 31 0.89 0.63-1.25
  5-14    342 36 82 30 0.85 0.59-1.21
  15-24    265 51 65 33 1.00        -
  25-39    621 51 76 39 1.30 0.95-1.78
  40-64    487 50 85 42 1.50 1.08-2.07
  65+    254 35 92 32 0.89 0.61-1.30
Urbaniztion   ni
  Low    305 34 94 32
Intermediate 1,654 46 79 37
  High    582 45 72 32
Region
  North    281 60 83 49 2.16 1.63-2.87
  East    586 33 84 28 0.86 0.68-1.08
  West 1,034 41 73 30 1.00        -
  South    642 53 81 43 1.69 1.36-2.08
Year of study
  May 96-Apr 97    804 59 80 47 1.00
  May 97-Apr 98    841 40 81 32 0.50 0.43-0.65
  May 98-Apr 99    889 34 77 26 0.40 0.33-0.50
Total 2,553 45 78 35    -        -
aGP - general practitioner
bpart = participating.
cOR = odds ratio for participation (defined as a case questionnaire received at the National Institute of Public Health and the
Environment).
dCI = confidence interval.
eni = not included in the logistic regression model.
Table 3. Self-reported symptoms of patients, Netherlands
case-control study
No. of cases
  (N=878) % of cases
Loose stools 861 98.1
Frequent stoolsa 387 78.2
Abdominal cramps 679 77.3
Abdominal pain 673 76.7
Nausea 536 61.0
Vomiting 359 40.9
Fever 335 38.2
Mucus in stool 304 34.6
Blood in stool   97 11.0
aMore frequent than normal as perceived by the respondent.
not meet the case definition; 14% consulted for
other reasons (e.g., to pick up a prescription,
routine physical examination, accompanying a
relative); most controls gave no information (43%)
or had consultations for other symptoms (36%).87 Vol. 7, No. 1, January–February 2001 Emerging Infectious Diseases
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In 37.5% of patients and 9.8% of controls, a
pathogen could be detected (excluding possibly
nonpathogenic microorganisms, Table 4). From
May 1998 until May 1999, these percentages
were increased by Sapporo-like viruses with 1.7%
in patients and 0.6% in controls. When D. fragilis
was considered a pathogen, these percentages
were 44.1% and 22.9%, respectively. The
percentage in which a pathogen was found was
similar for the 50 controls who reported
gastrointestinal symptoms (but did not meet the
case definition) and controls without gastrointes-
tinal symptoms.
Most stool samples of patients were received
at the National Institute within 1 day of
collection (57%), 21% after 2 days, 9% after 3
days, 7% after 4 days, 3% after 5 days, and 2%
after  >6 days. No significant differences were
noted in the percentage of samples in which a
pathogen was detected for different postal
delays. For Campylobacter, however, a decreas-
ing trend in the proportion of positive cases was
observed with an increasing postal delay: 1 day:
12% positive, 2 days: 10%, 3 days: 9%, 4 days: 6%,
5 days 5%, 6 days or more: no Campylobacter.
Discussion
Incidence and Participation Rate
This is the first GP-based national study in
the Netherlands covering the role of a wide range
of microorganisms in a representative population
of gastroenteritis patients and controls. Only
England has conducted a similar study.
The incidence of gastroenteritis in general
practices was estimated at 79.7 per 10,000 person
years, suggesting that in the Netherlands, 1 in
every 125 persons, or 128,000 persons, will seek
physician care for gastroenteritis every year.
This estimate was adjusted for list inflation and
partially for nonparticipation (15%) of GPs but
not for the number of underascertained cases
absent from both study components. In a similar
study in England, underascertainment was
estimated to be 36% (23). The correction for list
inflation (2.5%) in our study should be considered
a minimum estimate because only patients who
were actively reported as no longer belonging to
the general practice population were counted; by
contrast, the more active approach in England
(searching medical records of nonrespondents)
Table 4. Microorganisms detected in patients and controls
Patients Controls
(N=857) (N=574)
  N    %    N    %
Salmonella spp.   33   3.9     1   0.2
    S. Enteritidis   12   1.4     0   0.0
    S. Typhimurium   11   1.3     1   0.2
    other Salmonellaea     9   1.1     0   0.0
Campylobacter spp.   89 10.5     3   0.5
    C. jejuni   77   9     3   0.5
    C. coli     7   0.8     0   0.0
    other species     5   0.6     0   0.0
Yersinia spp.     6   0.7     6   1.1
    Y. enterocoliticab     5   0.6     5   0.9
    Y. frederikseniic     1   0.1     1   0.2
Shigella spp.     1   0.1     0   0.0
    S. flexneri     1   0.1     0   0.0
VTECd     4   0.5     3   0.6
Rotavirus   45   5.3     8   1.4
Adenovirus   19   2.2     2   0.4
Astrovirus   13   1.5     2   0.4
Norwalk-like viruses   43   5.0     6   1.1
Sapporo-like virusese     5   2.1     1   0.6
Giardia lamblia   46   5.4   19   3.3
Entamoeba histolytica/     9   1.1     4   0.7
  dispar
Cryptosporidium   18   2.1     1   0.2
Cyclospora     1   0.1     1   0.2
(Possibly) nonpathogenic
  microorganisms
    Dientamoeba fragilis   88 10.3   84 14.6
    Blastocystis hominis 185 21.7 172 30.0
    Endolimax nana   14   1.6   14   2.4
    Enteromonas hominis     2   0.2     1   0.2
    Chilomastix mesnili     1   0.1     0   0.0
    Entamoeba hartmanni     0   0.0     2   0.4
    Enterobius vermicularis     0   0.0     1   0.2
    Iodamoeba butschlii     0   0.0     1   0.2
aS. Heidelberg, S. Thompson, S. Kottbus, S. Montevideo,
S. Manhattan, S. Anatum, S. Arizona, Salmonella group B
(not fully typeable).
bSerotypes of Y. enterocolitica in patients: O6,31 (biotype
1a), O6,30; O6,30 (biotype 1A), one not typeable, one not
typed. In controls: two O4 (biotype 1A); O65 (biotype 1A),
O7,8 (biotype 1A); one not typeable.
cSerotypes of Y. frederiksenii: O16a,58 (case); O16AB,29
(control).
dVTEC=verocytotoxin-producing Escherichia coli: positive
for eae gene and genes for either SLT1 or SLT2. VTEC
serotypes in cases: O157 K-H-, O98 K-, O145 K-, one not
typeable. In controls: O26, O145 K-, one not typeable
eSapporo-like viruses have only been tested for the last
study year (May 98–Apr 99; 240 cases and 160 controls).
Genotypes in cases: 4 Sapporo, 1 London, genotype in
control: Sapporo.88 Emerging Infectious Diseases Vol. 7, No. 1, January–February 2001
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yielded an  estimate of 10% (23). Consequently,
the incidence from our study must be considered
a conservative, but the best available, estimate.
A previous estimate of the incidence of
gastroenteritis in a GP-based study in 1992 to
1993 in the Netherlands was somewhat higher at
90 cases per 10,000 person years (not corrected
for list inflation) (8). Since the percentages of
Salmonella  and  Campylobacter  have also
decreased since 1992-1993 (from 5% to 4% and
from 14% to 10%, respectively), the decrease in
incidence could partially be due to preventive
measures in the poultry industry that focused on
Salmonella  Enteritidis, but as expected, also
caused a slight decrease in Campylobacter
infections in poultry. Nevertheless, these mea-
sures were not fully implemented until April
1997, and therefore a decreasing trend in the
incidence within the study period would be
expected, which was not observed for gastroen-
teritis as a whole, nor for the percentages positive
for Salmonella and Campylobacter. Several other
factors might have contributed to this decrease,
such as a more widespread use of Hazard
Analysis and Critical Control Points in the food
production industry, greater awareness and
knowledge in the population about foodborne
infections, and a change in consultation behavior
because of GPs’ increasing deferral policy for
gastroenteritis.
The low incidence in the first study year was
presumably due to the absence of a winter peak in
1996 to 1997. Such peaks coincide with an
increase in infections with enteric viruses, such
as astrovirus, rotavirus, and calicivirus (24-26).
Therefore, the variation in incidence in different
years likely is due to the annual fluctuation of the
peaks in viral pathogens.
Our data indicate an incidence almost
fourfold lower than the incidence in England. The
GP-based incidence of gastroenteritis estimated
for England in a study from 1993 to 1996 was 330
per 10,000 person years after correction for list
inflation and underreporting (27). In Wales in
1992, an incidence of 244 per 10,000 person years
was found (28). Most likely, gastroenteritis
patients’ higher consultation rate in England
accounts for the difference: approximately 1 in 6
gastroenteritis case-patients in England consult
a GP, whereas an estimated 1 patient in 10 to 1
patient in 50 does in the Netherlands (5,6,8). A
lower consultation rate could be explained by
Dutch GPs’ policy of deferring gastroenteritis
cases. In the Dutch Guidelines for Acute
Diarrhea, a consultation by telephone is
considered adequate for uncomplicated acute
diarrhea and can be dealt with by the GP’s
assistant (29). Of the 19 participating GPs who
completed a questionnaire at the end of our
study, 12 (63%) reported fully or partially
discouraging patients with gastroenteritis from
visiting their practice. In England, a deferral
policy for consultations for gastroenteritis is not
common.
The incidence of gastroenteritis was indepen-
dently associated with degree of urbanization
and geographic region. The incidence was the
lowest in the North, as was found in the study in
1992 to 1993 (8). This cannot be explained by a
lower response rate (Table 2). A higher incidence
was found in areas with a high or low degree of
urbanization than in areas with an intermediate
degree of urbanization. Other studies also report
a higher incidence in urban areas (30). Possibly, a
high population density causes an increased risk
for person-to-person transmission. In rural
areas, contact with animals, manure, and raw
products could be more frequent than in more
urbanized regions, possibly leading to higher
levels of exposure to zoonotic pathogens. An
analysis of risk factors for each pathogen will be
published after an ongoing population-based
study is completed. The differences in incidence
could also reflect differences in consultation
behavior.
Patient-related factors that were indepen-
dently associated with incidence were patient’s
gender and age. The incidence was higher for
women than for men and was clearly higher in
the youngest age groups, consistent with other
studies (5,8,28,31-33). Although several studies
have reported a higher disease burden for the
elderly, no increase in the incidence of
gastroenteritis was observed in our study (1).
Possibly, the higher risk for gastroenteritis for
the elderly is limited to the relatively weaker
persons living in nursing homes (25). Because
these homes usually have their own GP, the
proportion of persons living in nursing homes
could be underrepresented in this study.
Pathogens
Bacteria were detected in 16.3% of patients,
viruses in 15.4%, and pathogenic parasites in89 Vol. 7, No. 1, January–February 2001 Emerging Infectious Diseases
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8.3%. The higher participation of the northern
region might have increased the percentage of
Salmonella Typhimurium because S. Typhimuri-
um is predominant over S. Enteritidis in this
region, in contrast to the rest of the Netherlands
(34). The order of relative importance of
pathogens in general practices was similar for
the Netherlands and England, although the
percentages positive for viruses and bacteria in
this study were slightly lower than in England
and the percentages positive for parasites were
slightly higher. Because bacteria and viruses are
more often detected in patients with acute
diarrhea, whereas parasites tend to cause less
fulminant but intermittent and long-lasting
symptoms that might lead to delayed consulta-
tion, these differences could be due to the
exclusion of persons with symptoms lasting
longer than 2 weeks in the English study (35,36).
In our study, 32% of patients had symptoms >2
weeks’ duration (36). In addition, we used
formalin-fixed material to detect parasites, and
four different preparations were examined,
which increased the sensitivity of microscopy
examination, compared to the use of nonfixed
material and the examination of three different
preparations in the English study (37). The lower
participation of patients in the last 2 years of the
study might have caused an underestimate of
viral pathogens because the seasonal viral peak
was relatively low in the first year (24,38). In
spite of a less sensitive method of testing for
Norwalk-like viruses (electron microscopy in
England versus reverse transcriptase-poly-
merase chain reaction in the Netherlands), the
percentage of stool samples positive for Norwalk-
like viruses is higher in England (36). The low
response for the younger age groups might also
have reduced the percentage of rotavirus,
Sapporo-like viruses, and to a lesser degree
Norwalk-like viruses, which are most common in
young children (24). Differences in the proportion
of specific pathogens in the English study and in
our study may also be explained by differences in
consultation rates. A lower threshold for
consulting a GP might increase the proportion of
pathogens that cause relatively mild gastroen-
teritis, such as Norwalk-like viruses.
Parasites that were (possibly) nonpathogenic
were more frequently found in controls than in
patients. A more detailed study of differences
between patients and controls with these parasites
might identify factors related to the development
of disease after infection with these parasites.
Diagnostic Deficit
In spite of a diagnostic panel that included
most of the known pathogens that can cause
gastroenteritis, the percentage of patients in
which no pathogen could be detected was 61%
(including Sapporo-like viruses in 1998 and
excluding  D. fragilis and nonpathogenic para-
sites). Some cases could be noninfectious because
an exclusive distinction between infectious and
noninfectious intestinal disease cannot be made
clinically. The high percentage of patients with
chronic gastrointestinal symptoms suggests that
a substantial proportion might not be infectious
but an expression of other illnesses, such as
inflammatory bowel disease. The symptoms
might also be caused by intestinal microorgan-
isms not included in this study or not yet known.
Several pathogens, such as Campylobacter,
verocytotoxin-producing E.  coli, and torovirus
have only recently been recognized as a cause of
gastroenteritis, and it is likely that new
pathogens will be added to this list (39). In
addition, we did not screen for some pathogens,
such as some pathogenic E. coli (e.g., enterotoxi-
genic E. coli, enteroinvasive E. coli) and bacterial
toxins (Bacillus spp, Clostridium difficile cytotoxin,
C. perfringens enterotoxin), which were associat-
ed with 15% and 6% of the cases, respectively, in
the English study (36). However, all stool samples
from our study were stored and are currently being
tested for Sapporo-like viruses and can be tested
for other pathogens. Also, intestinal symptoms
can be caused by nonintestinal infections, such as
influenza, not included in our study. Approxi-
mately one quarter of gastroenteritis cases in an
American population-based study coincided with
respiratory disease (31). Detection of pathogens
in the study is also influenced by logistics factors
and the sensitivity of the testing method. The
timing of sampling was not ideal in many cases;
because of the relatively long patient delay, some
pathogens might no longer have been excreted in
the stool at the time of sampling. Some
pathogens, such as Campylobacter, do not grow
in culture after a long delay in shipping. At
present, we are conducting a study on
gastroenteritis in the community to elucidate the
role of sampling time and referral behavior on
pathogen-specific incidence.90 Emerging Infectious Diseases Vol. 7, No. 1, January–February 2001
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